|
Vaccine Detail
ALVAC-RV |
Vaccine Information |
- Vaccine Name: ALVAC-RV
- Target Pathogen: Rabies virus
- Target Disease: Rabies
- Vaccine Ontology ID: VO_0004728
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- Vector:
- Preparation: A non-adjuvanted feline rabies vaccine developed using the canarypoxvirus vector (Jas et al., 2012).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Cat Response
- Vaccination Protocol: Seronegative cats were vaccinated at 12 weeks of age and received a booster vaccination one year later (Jas et al., 2012).
- Vaccine Immune Response Type: VO_0000287
- Challenge Protocol: The cats were challenged by inoculation of 1 mL of rabies virus in the neck muscles (0.5 mL on the left and right side of the spine). The inoculum was a homogenate of salivary glands of foxes and each cat received 10^7.7 mouse Lethal Dose 50, the equivalent of 10^6.8 CCID50.
- Efficacy: This vaccination regimen induced a strong and sustained antibody response, and all vaccinated animals were protected against virulent rabies challenge carried out 3 years after vaccination (Jas et al., 2012).
|
References |
Jas et al., 2012: Jas D, Coupier C, Toulemonde CE, Guigal PM, Poulet H. Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine. Vaccine. 2012; 30(49); 6991-6996. [PubMed: 23059358].
|
|